Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.81B |
| 2 |
Microsoft
MSFT
|
+$1.34B |
| 3 |
Apple
AAPL
|
+$1.25B |
| 4 |
Amazon
AMZN
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$480M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$373M |
| 2 |
Amgen
AMGN
|
+$204M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$180M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$160M |
| 5 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.47% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 12.22% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
XBiotech
XBIT
$69.2M
| $1.59M | ﹤0.01% |
195,204
+2,616
| +1% | +$15K |
|
3202
Cue Biopharma
CUE
$114M
| $1.59M | ﹤0.01% |
27,951
+841
| +3% | +$59.3K |
|
3203
D-Wave Quantum Inc. Common Stock
QBTS
$7.73B
| $1.58M | ﹤0.01% |
775,634
+68,669
| +10% | +$96.5K |
|
3204
Acme United Corp
ACU
$215M
| $1.58M | ﹤0.01% |
33,544
+794
| +2% | +$36K |
|
3205
Motorcar Parts of America
MPAA
$258M
| $1.57M | ﹤0.01% |
195,129
-3,833
| -2% | -$34.5K |
|
3206
Canadian Solar
CSIQ
$1.08B
| $1.57M | ﹤0.01% |
79,345
-237
| -0.3% | -$5.11K |
|
|
NGM
3207
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $1.56M | ﹤0.01% |
983,836
+62,226
| +7% | +$92.3K |
|
3208
RCM Technologies
RCMT
$208M
| $1.56M | ﹤0.01% |
73,176
+5,771
| +9% | +$159K |
|
3209
Kornit Digital
KRNT
$791M
| $1.56M | ﹤0.01% |
86,194
+730
| +0.9% | +$12.8K |
|
3210
ProKidney
PROK
$337M
| $1.56M | ﹤0.01% |
949,517
+50,844
| +6% | +$74.7K |
|
3211
Vuzix
VUZI
$224M
| $1.55M | ﹤0.01% |
1,281,549
+761
| +0.1% | +$1.24K |
|
3212
1stdibs.com
DIBS
$171M
| $1.55M | ﹤0.01% |
259,177
+18,617
| +8% | +$94.7K |
|
3213
Neuropace
NPCE
$506M
| $1.54M | ﹤0.01% |
116,960
+964
| +0.8% | +$13.8K |
|
3214
Taylor Devices
TAYD
$175M
| $1.54M | ﹤0.01% |
30,870
-294
| -0.9% | -$10.3K |
|
3215
PMV Pharmaceuticals
PMVP
$63.5M
| $1.54M | ﹤0.01% |
903,137
+42,801
| +5% | +$79.9K |
|
|
CALB
3216
DELISTED
California BanCorp Common Stock
CALB
| $1.53M | ﹤0.01% |
69,613
+3,894
| +6% | +$91.4K |
|
3217
Lifecore Biomedical
LFCR
$190M
| $1.52M | ﹤0.01% |
286,962
+1,877
| +0.7% | +$13.4K |
|
|
CBIO
3218
Crescent Biopharma
CBIO
$626M
| $1.52M | ﹤0.01% |
5,051
+262
| +5% | +$78.3K |
|
3219
loanDepot
LDI
$516M
| $1.52M | ﹤0.01% |
585,049
+35,388
| +6% | +$95.1K |
|
3220
Noodles & Co
NDLS
$107M
| $1.52M | ﹤0.01% |
99,159
+538
| +0.5% | +$10.5K |
|
|
CCRD
3221
DELISTED
CoreCard
CCRD
| $1.52M | ﹤0.01% |
137,111
+2,713
| +2% | +$32.3K |
|
3222
Smartbird Inc
BIRD
$22.3M
| $1.5M | ﹤0.01% |
108,382
+2,677
| +3% | +$49.9K |
|
3223
HireQuest
HQI
$185M
| $1.5M | ﹤0.01% |
116,099
+2,074
| +2% | +$27.4K |
|
3224
Atara Biotherapeutics
ATRA
$76.1M
| $1.5M | ﹤0.01% |
86,344
+338
| +0.4% | +$6K |
|
3225
LiveWire
LVWR
$221M
| $1.49M | ﹤0.01% |
205,922
+30,697
| +18% | +$294K |
|
Similar funds
Geode Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Geode Capital Management held 4,738 positions worth $1.08T, up 13% from $956B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Geode Capital Management deployed $32.6B of net new capital in Q1 2024, opening 85 new positions and adding to 3,720 existing holdings. Its largest new stake was Solventum: 2,733,775 shares worth $0.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $204M trimmed.
- Geode Capital Management's largest Q1 2024 buy was Solventum: 2,733,775 shares worth $0.
- Geode Capital Management added most to NVIDIA in Q1 2024, an estimated $1.81B increase.
- Geode Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $204M.
- Geode Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $373M.
- Geode Capital Management's ten largest holdings make up 28% of its $1.08T portfolio in Q1 2024.
- Geode Capital Management opened 85 new positions and closed 123 in Q1 2024.
- Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $1.08T.
Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.